New Coverage Options for GLP-1s with Employer HRA

As demand for GLP-1 medications continues to grow, many folks are looking for ways to manage the hefty price tag. A new solution is available in 2026: a GLP-1 Health Reimbursement Arrangement (HRA) offered through TASC. So how does it work?

A Health Reimbursement Arrangement (HRA) is an employer-funded benefit that reimburses employees for eligible healthcare expenses. At the start of the year, employers set aside funds for employees to use on approved medical expenses. When employees pay for said medical expenses, they can be reimbursed tax-free from the HRA. 

Unlike other reimbursement plans, HRAs are highly customizable by the employer. They can determine not only contribution amounts but also eligibility requirements and which expenses and medications are covered. In 2026, GLP-1s can now be included as one of those covered expenses.

The GLP-1 HRA is a specialized version of a traditional HRA, designed specifically to help manage the cost of GLP-1 medications. Employers can define exactly which GLP-1 medications are eligible and who qualifies for reimbursement. If an employee is reimbursed for their GLP-1 medication, that reimbursement uses pre-tax dollars, which saves money for both the employer and the employee. This method of reimbursement can be used for any medication as well, not just GLP-1s.

This approach gives employers more control over plan design while still supporting employees who need access to these medications. If GLP-1s aren’t currently covered by your health plan, employers can introduce this benefit as a targeted solution.

With healthcare costs continuing to rise, many employers are looking for more options to help their employees cover costs. If you are an employer interested in learning more about how an HRA may work for your company, get in touch! We’re happy to walk you through the various options available to you through a HRA.